CVE-2026-5135A flaw was found in Foreman.
Updated under an hour ago ()
Does this affect you?
It affects redhat satellite and 1 other product. Add what you run to find out whether that includes you.
No exploitation reported and no EPSS estimate yet.
Do this next
Free account, 1 product
A flaw was found in Foreman. This broken access control vulnerability allows an authenticated user with host-edit permissions to retarget an existing lookup value override to a different host. This is achieved by modifying the match field through nested host attributes, effectively bypassing authorisation checks. The consequence is the potential for unauthorised modification of managed host configurations across different organisational and location boundaries.
- CVSS
- 6.5 MEDIUM (v3.1, NVD)CVSS:3.1/AV:N/AC:L/PR:L/UI:N/S:U/C:N/I:H/A:N
- Weakness (CWE)
- CWE-639
- Known exploited
- Not in CISA's KEV catalog
- EPSS (exploitation in the next 30 days)
- Not loaded for this CVE
- Assigned by
- Not given
- NVD analysis
- Analyzed
- Record last updated
- Jul 9, 2026
- First seen by InfoSec Signals
- Oct 9, 2026
Affected products
redhat satellite redhat:satellite | from 6.16 before 6.16.10; from 6.17 before 6.17.9; from 6.18 before 6.18.7; from 6.19 before 6.19.2 | NVD |
theforeman foreman theforeman:foreman | before 3.18.2; from 3.19.0 before 3.19.1 | NVD |
References
- https://access.redhat.com/errata/RHSA-2026:34365vendor-advisory
- https://access.redhat.com/errata/RHSA-2026:34366vendor-advisory
- https://access.redhat.com/errata/RHSA-2026:34367vendor-advisory
- https://access.redhat.com/errata/RHSA-2026:34368vendor-advisory
- https://access.redhat.com/security/cve/CVE-2026-5135vendor-advisory
- https://bugzilla.redhat.com/show_bug.cgi?id=2452230issue-tracking, vendor-advisory
The CVE record on cve.org NVD's entry
The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.